BCG Therapy (Bacillus Calmette-Guérin Therapy)

BCG therapy uses a weakened form of a bacteria called Bacillus Calmette-Guérin to treat bladder cancer. When introduced into the bladder, it helps the immune system recognize and attack cancer cells. This treatment is typically used for non-muscle invasive bladder cancer and can reduce the risk of cancer returning or progressing. BCG therapy is generally well-tolerated, although some patients may experience mild side effects like bladder irritation or flu-like symptoms. It harnesses the body's infection-fighting mechanisms to specifically target and combat cancer within the bladder.